Ratings

The low quality of drugs at the end point is alarming

I work for PLoS but I was alerted to this article via the NY Times, which I was pleased to see cover it and highlight how the threat of counterfeit/substandard antimalarials, thought by me to be a problem largely confined to SE Asia, is growing in Africa. Thank you for this important and well presented article.

This insightful study conducted by the highly competent non-profit health advocacy group "Africa Fighting Malaria" is insightful and provocative, and has indeed provided yet another critical platform for positive discussion and action for those engaged in the global malaria effort. H Hannesson

...without positive and negative controls one cannot judge the reliability of the analytical methods and by extension the data reported herein.